Research providing critical insight into the prognosis and clinical treatment course of people with a certain subtype of Multiple Sclerosis (MS) discussed at AAN meetings

Stuart SchlossmanMS Research Study and Reports

April 2011 –  In a study titled “Evaluation of Progressive Relapsing MS Patients in the PROMISE Trial,” Fred Lublin, MD, Saunders Family Professor of Neurology and the Director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis at The Mount Sinai Medical Center and Michelle Fabian, MD, Neurology Fellow at Mount Sinai School of Medicine, conducted a subanalysis of the PROMISE trial. The clinical trial is a multinational, multicenter, double-blind, placebo-controlled trial evaluating the effects of glatiramer acetate treatment over three years in patients with primary progressive multiple sclerosis (PPMS). PPMS is characterized by steady , rather than attacks or exacerbations followed by remissions, which people with relapsing-remitting MS experience.
“We were able to analyze data from a well-controlled clinical trial to determine the frequency and clinical consequences of the occurrence of relapses in MS patients who initially have a progressive course,” said Dr. Lublin. “Our data indicate that baseline characteristics and disease progression in PRMS differ from those in PPMS. As such, clinicians should consider evaluating the PRMS subgroup differently from those with PPMS in assessing prognosis and clinical course.”
Click to continue reading

====================

****************************************************************
Remain CURRENT with Multiple Sclerosis information 
 when registered at the  MS Views and News  website

.

***************************************************************************************

Help to Educate:  Please donate   – all contributions are tax deductible – 

.

“Providing You with ‘MS Views and News’, is what we do“
***************************************************************************************

.

Disclaimer:  ‘MS Views and News’ (MSVN), does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

.
 ****************************************************************
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews